NO137341C
(en)
*
|
1972-10-02 |
1978-02-15 |
Tavolek Laboratories |
RODENTICID PREPARATION INCLUDING COATED PARTICLES OF SUBSTITUTED NORBORNEN DIKAR BOXIMIDES
|
DE2532147B2
(en)
*
|
1975-07-18 |
1981-06-25 |
Renker GmbH, 5160 Düren |
Process for the production of microcapsules containing oil
|
US4357259A
(en)
*
|
1977-08-01 |
1982-11-02 |
Northwestern University |
Method of incorporating water-soluble heat-sensitive therapeutic agents in albumin microspheres
|
US4247406A
(en)
|
1979-04-23 |
1981-01-27 |
Widder Kenneth J |
Intravascularly-administrable, magnetically-localizable biodegradable carrier
|
WO1985005029A1
(en)
*
|
1984-05-09 |
1985-11-21 |
Medaphore Inc. |
Oral insulin and a method of making the same
|
USRE35862E
(en)
*
|
1986-08-18 |
1998-07-28 |
Emisphere Technologies, Inc. |
Delivery systems for pharmacological agents encapsulated with proteinoids
|
US6331318B1
(en)
|
1994-09-30 |
2001-12-18 |
Emisphere Technologies Inc. |
Carbon-substituted diketopiperazine delivery systems
|
US6099856A
(en)
|
1992-06-15 |
2000-08-08 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5578323A
(en)
|
1992-06-15 |
1996-11-26 |
Emisphere Technologies, Inc. |
Proteinoid carriers and methods for preparation and use thereof
|
US5714167A
(en)
|
1992-06-15 |
1998-02-03 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5443841A
(en)
*
|
1992-06-15 |
1995-08-22 |
Emisphere Technologies, Inc. |
Proteinoid microspheres and methods for preparation and use thereof
|
US5541155A
(en)
|
1994-04-22 |
1996-07-30 |
Emisphere Technologies, Inc. |
Acids and acid salts and their use in delivery systems
|
US6221367B1
(en)
|
1992-06-15 |
2001-04-24 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5629020A
(en)
|
1994-04-22 |
1997-05-13 |
Emisphere Technologies, Inc. |
Modified amino acids for drug delivery
|
US5693338A
(en)
|
1994-09-29 |
1997-12-02 |
Emisphere Technologies, Inc. |
Diketopiperazine-based delivery systems
|
US5447728A
(en)
|
1992-06-15 |
1995-09-05 |
Emisphere Technologies, Inc. |
Desferrioxamine oral delivery system
|
US5811127A
(en)
|
1992-06-15 |
1998-09-22 |
Emisphere Technologies, Inc. |
Desferrioxamine oral delivery system
|
US5792451A
(en)
|
1994-03-02 |
1998-08-11 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
US5401516A
(en)
|
1992-12-21 |
1995-03-28 |
Emisphere Technologies, Inc. |
Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
|
US5643957A
(en)
|
1993-04-22 |
1997-07-01 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5958457A
(en)
|
1993-04-22 |
1999-09-28 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
US5709861A
(en)
|
1993-04-22 |
1998-01-20 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
EP1025840B1
(en)
|
1993-04-22 |
2005-06-29 |
Emisphere Technologies, Inc. |
Oral drug compositions
|
FR2727632A1
(en)
*
|
1994-12-06 |
1996-06-07 |
Godard Philippe |
Compsns. contg. perfume-filled microcapsules
|
US5989539A
(en)
|
1995-03-31 |
1999-11-23 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
BR9604880A
(en)
|
1995-03-31 |
1998-05-19 |
Emisphere Tech Inc |
Compound composition dosage unit form methods for administering a biologically active agent for preparing a composition for administering an active agent and for preparing a compound and pharmacological composition
|
US5650386A
(en)
|
1995-03-31 |
1997-07-22 |
Emisphere Technologies, Inc. |
Compositions for oral delivery of active agents
|
US6001347A
(en)
|
1995-03-31 |
1999-12-14 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5965121A
(en)
|
1995-03-31 |
1999-10-12 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6090958A
(en)
|
1995-03-31 |
2000-07-18 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5866536A
(en)
|
1995-03-31 |
1999-02-02 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5820881A
(en)
|
1995-04-28 |
1998-10-13 |
Emisphere Technologies, Inc. |
Microspheres of diamide-dicarboxylic acids
|
US5824345A
(en)
|
1995-06-07 |
1998-10-20 |
Emisphere Technologies, Inc. |
Fragrances and flavorants
|
US5750147A
(en)
|
1995-06-07 |
1998-05-12 |
Emisphere Technologies, Inc. |
Method of solubilizing and encapsulating itraconazole
|
US6051258A
(en)
|
1995-06-07 |
2000-04-18 |
Emisphere Technologies, Inc. |
Proteinoid emulsions and methods for preparation and use thereof
|
GB2320248B
(en)
|
1995-09-11 |
1999-04-14 |
Emisphere Tech Inc |
Method for preparing omega-aminoalkanoic acid derivatives from cycloalkanones
|
EP0904065A4
(en)
|
1996-06-14 |
2000-06-14 |
Emisphere Tech Inc |
Microencapsulated fragrances and method for preparation
|
US5990166A
(en)
|
1997-02-07 |
1999-11-23 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5804688A
(en)
|
1997-02-07 |
1998-09-08 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5879681A
(en)
|
1997-02-07 |
1999-03-09 |
Emisphere Technolgies Inc. |
Compounds and compositions for delivering active agents
|
US5939381A
(en)
|
1997-02-07 |
1999-08-17 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6358504B1
(en)
|
1997-02-07 |
2002-03-19 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5876710A
(en)
|
1997-02-07 |
1999-03-02 |
Emisphere Technologies Inc. |
Compounds and compositions for delivering active agents
|
US6060513A
(en)
|
1997-02-07 |
2000-05-09 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6313088B1
(en)
|
1997-02-07 |
2001-11-06 |
Emisphere Technologies, Inc. |
8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
|
US5863944A
(en)
|
1997-04-30 |
1999-01-26 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5962710A
(en)
|
1997-05-09 |
1999-10-05 |
Emisphere Technologies, Inc. |
Method of preparing salicyloylamino acids
|
US9822364B2
(en)
|
2008-03-11 |
2017-11-21 |
Yale University |
Compositions and methods for controlled delivery of inhibitory ribonucleic acids
|
ES2770273T3
(en)
|
2008-06-27 |
2020-07-01 |
Tepha Inc |
Injectable administration of microparticles and compositions therefor
|
CA2902762A1
(en)
|
2012-02-17 |
2013-08-22 |
Massachusetts Institute Of Technology |
Glucose-responsive microgels for closed loop insulin delivery
|
EA030318B1
(en)
|
2012-03-16 |
2018-07-31 |
Дзе Джонс Хопкинс Юниверсити |
Non-linear multiblock copolymer-drug conjugates for the delivery of active agents
|
US8962577B2
(en)
|
2012-03-16 |
2015-02-24 |
The Johns Hopkins University |
Controlled release formulations for the delivery of HIF-1 inhibitors
|
WO2014160404A1
(en)
|
2013-03-13 |
2014-10-02 |
The Regents Of The University Of California |
Improved oral drug devices and drug formulations
|
CN111195215A
(en)
|
2014-01-10 |
2020-05-26 |
室内作品有限责任公司 |
Personalizing substance for application to the skin or for addition to tattooing ink, and method for the production thereof
|
US20150320158A1
(en)
|
2014-03-14 |
2015-11-12 |
Chamber Works, Llc |
Articles of jewelry containing a personalizing additive such as dna and methods of making
|
EP3140269B1
(en)
|
2014-05-09 |
2023-11-29 |
Yale University |
Hyperbranched polyglycerol-coated particles and methods of making and using thereof
|
US11918695B2
(en)
|
2014-05-09 |
2024-03-05 |
Yale University |
Topical formulation of hyperbranched polymer-coated particles
|
US10722468B2
(en)
|
2014-08-14 |
2020-07-28 |
Brown University |
Compositions for stabilizing and delivering proteins
|
EP3233056B1
(en)
|
2014-12-15 |
2023-11-15 |
The Johns Hopkins University |
Sunitinib formulations and methods for use thereof in treatment of ocular disorders
|
EP3247406A1
(en)
|
2015-01-20 |
2017-11-29 |
The Johns Hopkins University |
Compositions for the sustained release of anti-glaucoma agents to control intraocular pressure
|
AR106018A1
(en)
|
2015-08-26 |
2017-12-06 |
Achillion Pharmaceuticals Inc |
ARYL, HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF MEDICAL DISORDERS
|
EP3340982B1
(en)
|
2015-08-26 |
2021-12-15 |
Achillion Pharmaceuticals, Inc. |
Compounds for treatment of immune and inflammatory disorders
|
CA2997442C
(en)
|
2015-09-04 |
2021-01-26 |
Yale University |
Polymeric bile acid nanocompositions targeting the pancreas and colon
|
EA038755B1
(en)
|
2015-11-12 |
2021-10-14 |
Грейбаг Вижн, Инк. |
Aggregating microparticles for providing sustained release of a therapeuic agent for intraocular delivery
|
US11136597B2
(en)
|
2016-02-16 |
2021-10-05 |
Yale University |
Compositions for enhancing targeted gene editing and methods of use thereof
|
WO2017143061A1
(en)
|
2016-02-16 |
2017-08-24 |
Yale University |
Compositions and methods for treatment of cystic fibrosis
|
US20190022016A1
(en)
|
2016-03-02 |
2019-01-24 |
The Johns Hopkins University |
Compositions for sustained release of anti-glaucoma agents to control intraocular pressure
|
AU2017290593A1
(en)
|
2016-06-27 |
2019-01-03 |
Achillion Pharmaceuticals, Inc. |
Quinazoline and indole compounds to treat medical disorders
|
WO2018053010A1
(en)
|
2016-09-13 |
2018-03-22 |
North Carolina State University |
Platelet compositions and methods for the delivery of therapeutic agents
|
US20200113821A1
(en)
|
2017-04-04 |
2020-04-16 |
Yale University |
Compositions and methods for in utero delivery
|
CN111201040A
(en)
|
2017-05-10 |
2020-05-26 |
灰色视觉公司 |
Sustained release microparticles and suspensions thereof for medical therapy
|
WO2020028907A1
(en)
|
2018-08-03 |
2020-02-06 |
Brown University |
Compositions and methods for improving the bioavailability of glp1 and analogues thereof
|
US20210189431A1
(en)
|
2018-08-10 |
2021-06-24 |
Yale University |
Compositions and methods for embryonic gene editing in vitro
|
CN116600789A
(en)
|
2020-06-19 |
2023-08-15 |
耶鲁大学 |
Polymeric bile acid ester nanoparticles for inducing tolerance
|
EP4251283A1
(en)
|
2020-11-27 |
2023-10-04 |
General Nanotherapeutics LLC |
Methods and composition for treatment of immune-mediated diseases
|
CA3234317A1
(en)
|
2021-10-22 |
2023-12-14 |
Wa Xian |
Methods and compositions for treating chronic inflammatory injury, metaplasia, dysplasia and cancers of epithelial tissues
|